Clinical Trial Update: Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating panitumumab plus best supportive care versus best supportive care in metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colorectal Cancer, Metastases | Phase 3 | Status: COMPLETED | Results posted: 2014-01-03